Page last updated: 2024-08-26

bosentan anhydrous and Ventricular Dysfunction

bosentan anhydrous has been researched along with Ventricular Dysfunction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duffy, JY; Lombardi, JP; Nelson, DP; Pearl, JM; Wagner, CJ1

Other Studies

1 other study(ies) available for bosentan anhydrous and Ventricular Dysfunction

ArticleYear
Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation.
    The Annals of thoracic surgery, 2001, Volume: 72, Issue:2

    Topics: Animals; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Infusions, Intravenous; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Receptors, Endothelin; RNA, Messenger; Sulfonamides; Swine; Ventricular Dysfunction

2001